Iconic Labs Share Price (ICON)

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Iconic Labs Plc LSE:ICON London Ordinary Share GB00BD060S65 ORD 0.001P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.0045 -21.43% 0.0165 127,828,272 16:08:02
Bid Price Offer Price High Price Low Price Open Price
0.015 0.018 0.021 0.0155 0.021
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
 
Last Trade Time Trade Type Trade Size Trade Price Currency
16:15:28 O 3,510,195 0.018 GBX

Iconic Labs (ICON) Latest News

Iconic Labs News

Date Time Source Headline
30/3/202014:06UKREGIconic Labs PLC Second Price Monitoring Extn
30/3/202014:01UKREGIconic Labs PLC Price Monitoring Extension
30/3/202008:11ALNCFAlliance News Flash Headline
30/3/202007:30UKREGIconic Labs PLC New project -- Infotagion Covid-19
30/3/202007:00UKREGIconic Labs PLC Re-Admission to trading and Restoration of Listing
27/3/202015:53UKREGIconic Labs PLC Admittance Of Previously Issued Shares
26/3/202007:00UKREGIconic Labs PLC Publication of a Prospectus
05/3/202014:36ALNCIconic Labs Inks Deal With Entertainment Presenter; Shares Suspended
05/3/202014:00UKREGIconic Labs PLC New GSN Marketing Agreement Signed
05/3/202007:35UKREGIconic Labs PLC Temporary Suspension
More Iconic Labs News
Iconic Labs Takeover Rumours

Iconic Labs (ICON) Discussions and Chat

Iconic Labs Forums and Chat

Date Time Title Posts
31/3/202016:55Iconic Labs ... UniLad v2.0 .. all new and improved reboot :)3,301
31/3/202015:45ICONIC LABS - New media and technology business5,677
30/3/202016:21Icon: the clue is in the name. I con. 31
28/2/202023:23New beginning 161
24/2/202017:40Iconic Labs PLC52

Add a New Thread

Iconic Labs (ICON) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:15:300.023,510,195631.84O
15:11:280.023,272,527589.05O
15:07:570.022,500,000450.00O
15:07:560.021,416,499240.80O
15:07:330.021,416,499240.80O
View all Iconic Labs trades in real-time

Iconic Labs (ICON) Top Chat Posts

DateSubject
31/3/2020
09:20		Iconic Labs Daily Update: Iconic Labs Plc is listed in the sector of the London Stock Exchange with ticker ICON. The last closing price for Iconic Labs was 0.02p.
Iconic Labs Plc has a 4 week average price of 0.02p and a 12 week average price of 0.02p.
The 1 year high share price is 0.29p while the 1 year low share price is currently 0.02p.
There are currently 0 shares in issue and the average daily traded volume is 559,861,639 shares. The market capitalisation of Iconic Labs Plc is £0.
Read Full Thread
Reply
19/2/2020
14:32		pwhite73: Yeah the share price is undervalued that's why they divided the nominal value by a factor of 250 down to 0.001p. Yep great confidence in a rising share price there.
Read Full Thread
Follow
Reply
09/2/2020
13:54		pwhite73: bernymadoff That's right £1 million market cap is nothing. But in order for the share price to double what needs to happen is for the company, its brokers, its nomads and EHGOS to sit on their hands and allow existing shareholders to reap the benefits of demand for the shares outstripping supply for the shares. The whole purpose of death spiral funding is not to allow this to happen. Any new money spent on ICON shares has to go EHGOS. They can only achieve this if existing share holders cannot compete for new money. There is only one way they can do this and it is to keep the share price below what everybody bought at. New investors love this because they are buying at an all time low like you did once. This is why through the technical process of how this type funding works your shares at 0.07p will soon trade at 0.05p whilst all the newbies will be screaming what you were screaming once - "The price of these shares are ridiculously cheap". Try and separate the company's mode of operation from yours as an existing share holder and ordinary private investor.
Read Full Thread
Follow
Reply
09/2/2020
12:30		pwhite73: What will happen next is that ICON will issue RNS news to try and shift more stock but as PIs buy EHGOS will convert at 90% VWAP lowering the share price on each conversion. The trick that needs to be performed is this. The news and subsequent PI buying has to outweigh the EHGOS conversions and dilutions. Only when that happens will you see a rise in the share price. The problem for you existing share holders is that just like yourselves new PIs are only interested in the stock at lower prices. They will do exactly what you guys have done buy when low. This is what death spirals are all about. The company and its backers are only interested in fresh money from new shareholders not returning money to existing shareholders. Death spirals can only function if existing shareholders can only sell at a loss. Therefore by default new shareholders must only be allowed to part with their cash for shares from the conversion loans and not from existing shareholders other wise EHGOS would not get paid back. This is why the share price is going down.
Read Full Thread
Follow
Reply
09/2/2020
10:14		pwhite73: bernymadoff - "EHGOS have reduced the amount payable by 30%. So the £1.375m outstanding is now £962,500." Wrong again. There were two agreements ICON entered into with EHGOS. There is the Deed of Issuance entered into on 06/08/2019. This was the £1.375m they have drawn down which has to be paid back in full. There was also the Deed of Settlement it entered into on 05/08/2019. This was an agreement to issue 237,827,207 shares to settle in full previous monies owed to EHGOS dating back to when ICON first starting using them. The shares could not be issued due to the share price being below the nominal value. The 'Deed of Issuance' and the 'Deed of Settlement' are two completely different agreements. It is the Deed of Settlement that ICON has agreed to reduce by 30%. You posted that part of the RNS yourself. Now here is the part that discusses the Deed of Issuance. RNS 07/2/2020 - "On 6 August 2019, the Company announced that it had secured further financing from European High Growth Opportunities Securitization Fund ....for a gross amount of up to £1.375 million, which would provide the Company with capital to continue to resolve the outstanding legacy issues associated with the previous operating stem cell business, fund the cash consideration elements for the acquisition of Social Alchemist and for general working capital purposes. This involved the Company entering into a deed of issuance with the Investor ("Deed of Issuance"). Now here is the part that discusses the Deed of Settlement. RNS - 07/02/2020 - "The Company also announced on 6 August 2019, that it had agreed to settle with the Investor the remaining amounts due that were outstanding under a previous financing agreement entered into with the Investor. This involved the Company entering into a deed of settlement on 5 August 2019 ("Deed of Settlement") pursuant to which the Company issued 237,827,207 ordinary shares to the Investor, with further ordinary shares to be issued once a number of conditions had been satisfied." Now here is the part that discusses them both. RNS - 07/02/2020 - "As background, the Deed of Issuance and Deed of Settlement were negotiated and secured in a situation whereby the Company had no other viable options for financing and urgently needed to resolve the liabilities from historic financing facilities, including penalties and debts incurred under agreements entered into by the old WideCells management team before the launch of the Company." Now here is the part that discusses a 30% reduction in the Deed of Settlement you have already posted it yourself but I will post it again in case yorgi modifies you for talking to me. RNS - 07/02/2020 - "The Financing and Settlement Agreement entered into with the Investor, involves, amongst other matters, the Investor agreeing to a 30 per cent. reduction of the total amounts it was owed under the Deed of Settlement."
Read Full Thread
Follow
Reply
08/2/2020
09:18		pwhite73: "Management recognises that the share price is currently being held back because of the dilutive effects of..." Yes so what have they gone and done? Re-engaged the same funding method that totally trashed the share price in the first place. But the truth of the matter is they had no choice. It was either billions upon billions more shares or time being called. No respectable finance house would touch this outfit with a barge pole.
Read Full Thread
Follow
Reply
28/1/2020
17:08		pwhite73: masqood You are correct about forward selling. That's where all these shares sub 0.070p for sale are coming from. The problem here is due to the share price being below the nominal value of 0.25p the sold shares cannot be crystallised into an RNS. There are only two ways around this. Firstly get the shares back up to 0.25p or secondly recapitalise. Both are nigh impossible at the moment because raising the share price to anywhere 0.25p will just lead to a stampede for the door. The brokers and nomads will require concrete evidence of revenues to put a recapitalisation to the authorities.
Read Full Thread
Follow
Reply
13/12/2019
08:17		pwhite73: sep800 - "And if passed new shares at 0.25p that almost 3 time higher than currently" Yes they can issue new shares at 0.25p and above which is three times the current share price. However to raise new money somebody has to be prepared to pay 0.25p per share when the shares are currently trading at 0.075p. If there was a buyer out there for shares at 0.25p they would not currently be trading at 0.075p. So to raise £1.375m at 0.25p per share one of two things has to happen. There has to be a 300% rise in the share price or the capital base of the shares has to be restructured. It is the second of the two that is going to take place. That is what the prospectus will reveal.
Read Full Thread
Follow
Reply
19/8/2019
07:32		pwhite73: From Gary Newman at share price .. It never ceases to amaze me how willing many private investors are to forget past failures and accept that a complete change of direction in a business is suddenly going to bring success. WideCells (WDC) failed as a stemcell research business, so it has now reinvented itself as a media and technology business, having changed its name to Iconic Labs (ICON), and many are immediately assuming that the new company will be a big success. A lot of the excitement seems to revolve around the previous involvement of Iconic CEO John Quinlan, and chief business officer Liam Harrington, in social publisher Unilad. What seems to be mentioned less often is that Unilad went into administration last September before a deal was finally done with LadBible to save the business, although it would be downsized, as LadBible owned a significant chunk of its debt. Around the same time as all this was going on, former LadBible creative lead Jono Yates, now working for Dugout, incorporated a company in the UK called Social Alchemist Ltd. Iconic (or WideCells as it was still known then) set up a media and technology division back in March, at the time Quinlan and Harrington joined the board. On August 6 an RNS landed stating that Iconic had signed a heads of terms agreement to purchase Social Alchemist using a mixture of cash and shares. What is strange though is that both parties are refusing to disclose the actual amount of the consideration being paid, and given that Iconic is a PLC I don’t really see how this information can be kept from shareholders. The RNS stated that Social Alchemist is ‘revenue generative, cash flow positive and profitable’ but no further indication is given as to exactly what extent – especially when it suddenly becomes part of Iconic, and with all of the corporate overheads that it has, I suspect it will be far from profitable at its current level – and it will be some time before we see the Social Alchemist accounts for the period in question. In early August the company also announced that it had secured up to £1.375 million, gross, of financing from the European High Growth Opportunities Securitization Fund over a six month period. The company has stated that it hopes that this financing will settle its outstanding debts – although there seems to be some confusion as to exactly what is still owed as it is still in dispute with creditors to the tune of £400,000, and if it loses then it would also be liable for that, although it has made a contingency for that. Looking at the way in which the funds are drawable over the six month period, and the fact that warrants are attached to them at a 10% discount to the volume weighted average price over the five days prior to exercise, or at the nominal value of the shares if that is higher. If they are exercised at nominal value then a fee is payable by Iconic equal to the difference in price. Currently the nominal value of the shares is 0.25p and the shares are trading at 0.15p, so things don’t exactly look great for the company unless it can turn that around quickly, as the warrants are exercisable as soon as they are issued, with a five year term. It also had to issue nearly 238 million shares to EHGO in settlement of previous debts, so that has given it an awful lot of firepower to sell and to keep the share price low – which is in its interests to do so whilst the finance is being drawndown over the coming months, as it will ensure that it receives a larger number of warrants (the amount issued is also based upon the VWAP over a five day period) and a guaranteed minimum exercise price of 0.25p (with Iconic being responsible for the difference, in money terms, for anything below that). So, taking all of this into account, the company is basically in a death spiral financing agreement, for an amount which may only settle all of its existing debts and leaving very little working capital, and with potentially huge amounts of shares to flood onto the market over the coming months. Based on all of this you have to wonder why on earth Social Alchemist would choose to sell to a company like this. If it really was a strong private company with such exciting prospects, it would easily be obtaining funding from angel investors/venture capitalists, or at the very least would sell to a listed company that had the funding available to accelerate growth – if it is as good as it sounds then they should have been queuing up for a piece of it. You certainly wouldn’t sell to a company that was in trouble, had little in the way of working capital, and little prospect of raising further capital. Don’t forget that Iconic can’t raise capital at below the nominal share value of 0.25p, which is around 65% above the current share price level. I suspect that the accounts of Social Alchemy are far less impressive than has been hinted at in the RNS – it could have a tiny revenue and profit, and still fit the description of it in that release. As if all of that wasn’t enough of a concern, the executive chairman of the company is David Sefton, who doesn’t exactly have the best track record to say the least. On top of that the company has been heavily pumped across social media, including by those who have a track record of being involved in causing brief spikes on micro cap companies before disappearing when the share price subsequently crashes. Often this is accompanied by rumours, or even fake articles sometimes, and in this case the story doing the rounds is of a £3 million deal with Sega! The market cap here is only £2 million so I suspect it will continue to be prone to wild share price swings, and some will benefit from trading that, but as an actual investment I can’t see any reason to buy it, with large amounts of further dilution due and the company in a position where it is unable to raise any further funds via an equity issue currently. I suspect that it will get rinsed by EHGO, and the £1.375 million debt is repayable after 12 months, along with a 5% interest rate, so where on earth is that money going to come from? Unless that debt also gets converted into shares and the death spiral financing continues. If you do try to have a trade here, just make sure you aren’t the one who ends up holding when it does come tumbling down.
Read Full Thread
Follow
Reply
18/8/2019
23:34		bumpa33: Beware any stock that serial junk pumper yorgi is pushing... From Gary Newman at share price .. It never ceases to amaze me how willing many private investors are to forget past failures and accept that a complete change of direction in a business is suddenly going to bring success. WideCells (WDC) failed as a stemcell research business, so it has now reinvented itself as a media and technology business, having changed its name to Iconic Labs (ICON), and many are immediately assuming that the new company will be a big success. A lot of the excitement seems to revolve around the previous involvement of Iconic CEO John Quinlan, and chief business officer Liam Harrington, in social publisher Unilad. What seems to be mentioned less often is that Unilad went into administration last September before a deal was finally done with LadBible to save the business, although it would be downsized, as LadBible owned a significant chunk of its debt. Around the same time as all this was going on, former LadBible creative lead Jono Yates, now working for Dugout, incorporated a company in the UK called Social Alchemist Ltd. Iconic (or WideCells as it was still known then) set up a media and technology division back in March, at the time Quinlan and Harrington joined the board. On August 6 an RNS landed stating that Iconic had signed a heads of terms agreement to purchase Social Alchemist using a mixture of cash and shares. What is strange though is that both parties are refusing to disclose the actual amount of the consideration being paid, and given that Iconic is a PLC I don’t really see how this information can be kept from shareholders. The RNS stated that Social Alchemist is ‘revenue generative, cash flow positive and profitable’ but no further indication is given as to exactly what extent – especially when it suddenly becomes part of Iconic, and with all of the corporate overheads that it has, I suspect it will be far from profitable at its current level – and it will be some time before we see the Social Alchemist accounts for the period in question. In early August the company also announced that it had secured up to £1.375 million, gross, of financing from the European High Growth Opportunities Securitization Fund over a six month period. The company has stated that it hopes that this financing will settle its outstanding debts – although there seems to be some confusion as to exactly what is still owed as it is still in dispute with creditors to the tune of £400,000, and if it loses then it would also be liable for that, although it has made a contingency for that. Looking at the way in which the funds are drawable over the six month period, and the fact that warrants are attached to them at a 10% discount to the volume weighted average price over the five days prior to exercise, or at the nominal value of the shares if that is higher. If they are exercised at nominal value then a fee is payable by Iconic equal to the difference in price. Currently the nominal value of the shares is 0.25p and the shares are trading at 0.15p, so things don’t exactly look great for the company unless it can turn that around quickly, as the warrants are exercisable as soon as they are issued, with a five year term. It also had to issue nearly 238 million shares to EHGO in settlement of previous debts, so that has given it an awful lot of firepower to sell and to keep the share price low – which is in its interests to do so whilst the finance is being drawndown over the coming months, as it will ensure that it receives a larger number of warrants (the amount issued is also based upon the VWAP over a five day period) and a guaranteed minimum exercise price of 0.25p (with Iconic being responsible for the difference, in money terms, for anything below that). So, taking all of this into account, the company is basically in a death spiral financing agreement, for an amount which may only settle all of its existing debts and leaving very little working capital, and with potentially huge amounts of shares to flood onto the market over the coming months. Based on all of this you have to wonder why on earth Social Alchemist would choose to sell to a company like this. If it really was a strong private company with such exciting prospects, it would easily be obtaining funding from angel investors/venture capitalists, or at the very least would sell to a listed company that had the funding available to accelerate growth – if it is as good as it sounds then they should have been queuing up for a piece of it. You certainly wouldn’t sell to a company that was in trouble, had little in the way of working capital, and little prospect of raising further capital. Don’t forget that Iconic can’t raise capital at below the nominal share value of 0.25p, which is around 65% above the current share price level. I suspect that the accounts of Social Alchemy are far less impressive than has been hinted at in the RNS – it could have a tiny revenue and profit, and still fit the description of it in that release. As if all of that wasn’t enough of a concern, the executive chairman of the company is David Sefton, who doesn’t exactly have the best track record to say the least. On top of that the company has been heavily pumped across social media, including by those who have a track record of being involved in causing brief spikes on micro cap companies before disappearing when the share price subsequently crashes. Often this is accompanied by rumours, or even fake articles sometimes, and in this case the story doing the rounds is of a £3 million deal with Sega! The market cap here is only £2 million so I suspect it will continue to be prone to wild share price swings, and some will benefit from trading that, but as an actual investment I can’t see any reason to buy it, with large amounts of further dilution due and the company in a position where it is unable to raise any further funds via an equity issue currently. I suspect that it will get rinsed by EHGO, and the £1.375 million debt is repayable after 12 months, along with a 5% interest rate, so where on earth is that money going to come from? Unless that debt also gets converted into shares and the death spiral financing continues. If you do try to have a trade here, just make sure you aren’t the one who ends up holding when it does come tumbling down.
Read Full Thread
Follow
Reply
08/8/2019
23:26		pwhite73: Your concern is not the dilution. It would be quite acceptable for EHGOS to own 99% of the company if the share price is at 1p. What DS is doing is extracting value from your holdings not by dilution but by issuing shares below the market price. That is what is killing the stock price and what death spiral financing is all about. DS is effectively transferring money held in the value of your stock into his and Iconic's bank accounts. The new death spiral finance is set at 90% of the share price and the warrants are set at 80%. Together these two will drive the share price lower than it is today and no amount of positive news can reverse this technical trend. Why do think even at this pathetic all time low price people are still bailing.
Read Full Thread
Follow
Reply
Iconic Labs share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
ICON
Iconic Lab..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200331 16:37:18